ARCHIVES

ASCO Urges Increase In Research Funding, Removal of Barriers For Trial Participation

This article is from The Cancer Letter archive.

Vol. 35 No. 03 | January 23, 2009

Download PDF Visit The Full Archive

Related Articles

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Maria Carolina Hinestrosa, EVP of National Breast Cancer Coalition

June 26, 2009

Beckman Coulter Offers Immunoassay System.

July 27, 2001

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

June 7, 2002

St. Jude Children’s wins NCI contract for Pediatric Preclinical Testing Program.

November 12, 2004